Patents by Inventor Irene Corthesy
Irene Corthesy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10537129Abstract: The present invention provides nutritional compositions, preferably printed, comprising at least one nutrient for which a deficiency in nutrient intake and/or nutrient status in a subject was detected. Such nutritional composition is comprised by an administration unit, and the nutrient is present at an amount corresponding to the difference between the target value and actual value of the nutrient intake and/or status in the subject. The invention further provides medical uses of such printed nutritional compositions, e.g. in the treatment or prophylaxis of malnutrition. The invention also provides administration units comprising such the nutritional compositions, as well as a system and method for producing the same.Type: GrantFiled: May 19, 2015Date of Patent: January 21, 2020Assignee: Societe des Produits Nestle S.A.Inventors: Irene Corthesy-Malnoe, Michael Jedwab
-
Publication number: 20180153842Abstract: A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.Type: ApplicationFiled: January 30, 2018Publication date: June 7, 2018Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
-
Patent number: 9884033Abstract: A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.Type: GrantFiled: January 14, 2016Date of Patent: February 6, 2018Assignee: Nestec S.A.Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
-
Publication number: 20170099867Abstract: The present invention provides nutritional compositions, preferably printed, comprising at least one nutrient for which a deficiency in nutrient intake and/or nutrient status in a subject was detected. Such nutritional composition is comprised by an administration unit, and the nutrient is present at an amount corresponding to the difference between the target value and actual value of the nutrient intake and/or status in the subject. The invention further provides medical uses of such printed nutritional compositions, e.g. in the treatment or prophylaxis of malnutrition. The invention also provides administration units comprising such the nutritional compositions, as well as a system and method for producing the same.Type: ApplicationFiled: May 19, 2015Publication date: April 13, 2017Inventors: Irene Corthesy-Malnoe, Michael Jedwab
-
Publication number: 20160128960Abstract: A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.Type: ApplicationFiled: January 14, 2016Publication date: May 12, 2016Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
-
Patent number: 9271958Abstract: The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.Type: GrantFiled: July 23, 2014Date of Patent: March 1, 2016Assignee: Nestec S.A.Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
-
Publication number: 20140335130Abstract: The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.Type: ApplicationFiled: July 23, 2014Publication date: November 13, 2014Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy Theulaz
-
Publication number: 20140056927Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or opthalmological applications, a food or petfood composition for modulating bacterial colonisaion, immune responses and decreasing the inflammatory processes, associated with bacterially mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and rectal cavity. The invention also relates to lipoteichoic acid selected thereof.Type: ApplicationFiled: August 15, 2013Publication date: February 27, 2014Applicant: NESTEC S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Patent number: 8394370Abstract: The present invention pertains to a composition for inducing a pattern of gut barrier maturation similar to that observed with breast-feeding and able to improve gut barrier maturation, e.g. during neonatal stress. In particular, the present invention relates to an infant formula containing a combination of specific ingredients designed to provide a synergistic effect all along gastrointestinal tract and barrier function.Type: GrantFiled: June 22, 2004Date of Patent: March 12, 2013Assignee: Nestec S.A.Inventors: Clara Lucia Garcia-Rodenas, Gabriela Bergonzelli, Florence Rochat, Marco Enrico Turini, Irène Corthesy-Theulaz, Christine Cherbut
-
Patent number: 8329190Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood composition for modulating bacterial colonization, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.Type: GrantFiled: October 7, 2008Date of Patent: December 11, 2012Assignees: Societe des Produits Nestle S.A., Nestec S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Publication number: 20120270786Abstract: The present invention generally relates to the field of nutrition and health. In particular, the present invention provides a composition that allows it to treat, limit or prevent muscle atrophy. Embodiments of the present invention are directed at GLP-2 containing compositions and to compositions that stimulate the secretion of GLP-2 in a body to treat or prevent muscle atrophy.Type: ApplicationFiled: October 7, 2010Publication date: October 25, 2012Applicants: I.N.R.A., NESTEC S.A.Inventors: Didier Attaix, Audrey Codran-Raison, Irene Corthesy-Theulaz, Denis Breuille, Lydie Combaret
-
Patent number: 8216605Abstract: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.Type: GrantFiled: October 12, 2004Date of Patent: July 10, 2012Assignee: Nestec S.A.Inventors: Irène Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
-
Patent number: 8021656Abstract: The present invention relates to a method of treating gut pain or gut discomfort related or linked to gut muscular abnormalities comprising the step of administering to a human or an animal having gut pain or gut discomfort an effective amount of a selected probiotic.Type: GrantFiled: July 23, 2003Date of Patent: September 20, 2011Assignee: Nestec S.A.Inventors: Irène Corthesy-Theulaz, Elena Verdu de Bercik, Premysl Bercik, Stephen Michael Collins
-
Patent number: 7910144Abstract: The present disclosure provides compositions intended for the prophylaxis or the treatment of disorders related to GHLO infections in pets, the compositions are prepared using at least one strain of lactic bacteria and/or one of its metabolites or a medium fermented by at least one lactic bacteria that has been isolated and selected for its ability to display a strong anti-Helicobacter bactericidal activity in vitro.Type: GrantFiled: July 15, 2002Date of Patent: March 22, 2011Assignee: Nestec S.A.Inventors: Oliver Ballevre, Iréne Corthesy-Theulaz, Adolphe MarcYves Enslen
-
Publication number: 20100028316Abstract: The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.Type: ApplicationFiled: June 12, 2009Publication date: February 4, 2010Applicant: Nestec S.A.Inventors: Irène Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
-
Publication number: 20090142375Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophtalmological applications, a food or petfood composition for modulating bacterial colonisation, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.Type: ApplicationFiled: October 7, 2008Publication date: June 4, 2009Applicants: SOCIETE DES PRODUITS NESTLE S.A., NESTEC S.A.Inventors: Karine Vidal, Anne Donnet-Hughes, Dominique-Anne Granato, Irene Corthesy-Theulaz
-
Publication number: 20080274127Abstract: The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.Type: ApplicationFiled: June 9, 2008Publication date: November 6, 2008Inventors: Magali Faure, Florence Rochat, Denis Breuille, Irene Corthesy-Theulaz
-
Publication number: 20070286935Abstract: The present invention is directed to procedures for the controlled natural bioprocessing of naturally occurring biological molecules by processing activities present in select organisms, extracts of such organisms or other natural processing agents. The invention also covers the methods for developing these procedures and compositions prepared by the procedures.Type: ApplicationFiled: October 7, 2005Publication date: December 13, 2007Applicant: NESTEC S.A.Inventors: Martin Grigorov, Peter Van Bladeren, Sunil Kochhar, Laurent-Bernard Fay, Irene Corthesy-Theulaz, Marcel-Alexandre Juillerat, Michael Affolter, Ulrich Zachariae
-
Publication number: 20070128178Abstract: The present invention relates to the use of proboscis in nutritional compositions or medicaments for the prevention of treatment of gut-neuromuscular abnormalities. Such abnormalities are, for example, associated with colic in babies, gut-pain or gut discomfort in general. In particular, the invention relates to the prevention or treatment of gut neuromuscular abnormalities after infection. Proboscis may be administered in a living or dead state, and also supernatant of fermentation medium may be directly used to achieve the beneficial effects reported herein.Type: ApplicationFiled: July 23, 2003Publication date: June 7, 2007Applicant: NESTEC S.A.Inventors: Iréne Corthesy-Theulaz, Elena Bercik, Premysl Bercik, Stephen Collins
-
Publication number: 20070122453Abstract: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.Type: ApplicationFiled: October 12, 2004Publication date: May 31, 2007Applicant: Nestec S.A.Inventors: Irene Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli